Agency Information Collection Activities: Proposed Collection; Comment Request, 19934-19935 [E7-7423]
Download as PDF
19934
Federal Register / Vol. 72, No. 76 / Friday, April 20, 2007 / Notices
both CDC and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office Centers for Disease Control
and Prevention.
[FR Doc. E7–7506 Filed 4–19–07; 8:45 am]
Dated: April 16, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–7520 Filed 4–19–07; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Centers for Disease Control and
Prevention
[Document Identifier: CMS–10217, CMS–R–
297 and CMS–10223]
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Minority HIV/AIDS
Research Initiative To Build Capacity
in Black and Hispanic Communities
and Among Black and Hispanic
Researchers To Conduct HIV/AIDS
Epidemiologic and Prevention
Research, Funding Opportunity
Announcement (FOA) Number PS07–
003
sroberts on PROD1PC70 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
Time and Date: 8:30 a.m.–9 a.m., May 17,
2007 (Open). 9 a.m.–4 p.m., May 17, 2007
(Closed).
Place: Sheraton Midtown Atlanta Hotel at
Colony Square, 188 14th Street, Atlanta, GA
30361.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of research applications received
in response to FOA PS07–003, ‘‘Minority
HIV/AIDS Research Initiative to Build
Capacity in Black and Hispanic Communities
and Among Black and Hispanic Researchers
to Conduct HIV/AIDS Epidemiologic and
Prevention Research.’’
For Further Information Contact: J. Felix
Rogers, PhD, M.P.H., Scientific Review
Administrator, Extramural Research Program
Office, Centers for Disease Control and
Prevention, 1600 Clifton Road, NE, MS E05,
Atlanta, GA 30333, telephone 404.639.6101.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
VerDate Aug<31>2005
18:52 Apr 19, 2007
Jkt 211001
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: New collection; Title of
Information Collection: Physician
Survey for the 2006 Medicare Oncology
Demonstration Program; Form Numbers:
CMS–10217 (OMB#: 0938–New); Use:
The 2006 Oncology Demonstration
Program aimed to: (1) Have oncology
payments increasingly focused on
patient-centered care, rather than
chemotherapy administration; (2) learn
to what extent Medicare beneficiaries
are being treated in a manner that yields
the best outcomes; (3) understand
clinical cancer scenarios where there is
not clinical consensus among
physicians on the relevance of specific
evidence-based practice guidelines; and,
(4) ensure that due emphasis is placed
on multi-disciplinary, comprehensive
approach to palliation and end of life
care. In addition, CMS hoped to reduce
the potential that unnecessary services
AGENCY:
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
and tests are being performed, thereby
lowering program costs while yielding
better quality of life for Medicare
beneficiaries with cancer. This survey
will provide information on how
physicians, particularly oncologists and
hematologists, adapted their practice in
response to the CMS payment incentive,
to guide future CMS demonstration
projects involving oncologists and all
specialists. Frequency: Reporting—
Once; Affected Public: Individuals or
households; Number of Respondents:
600; Total Annual Responses: 600; Total
Annual Hours: 100.
2. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Request for
Employment Information; Form
Numbers: CMS–R–297 (OMB#: 0938–
0787); Use: Section 1837(i) of the Social
Security Act provides for a special
enrollment period for individuals who
delay enrolling in Medicare Part B
because they are covered by a group
health plan based on their own or a
spouse’s current employment status.
When these individuals apply for
Medicare Part B, they must provide
proof that the group health plan
coverage is (or was) based on current
employment status. This form is used by
the Social Security Administration to
obtain information from employers
regarding whether a Medicare
beneficiary’s coverage under a group
health plan is based on current
employment status. Frequency:
Reporting—Once; Affected Public:
Business or Other for profit and Not-forprofit institutions; Number of
Respondents: 5000; Total Annual
Responses: 5000; Total Annual Hours:
1250.
3. Type of Information Collection
Request: New collection; Title of
Information Collection: Medicare
Competitive Acquisition Program (CAP)
for Part B Drugs Evaluation: CAP
Physician Survey; Form Numbers:
CMS–10223 (OMB#: 0938–New); Use:
This physician survey is part of an
overall evaluation of the Centers for
Medicare and Medicaid Services
congressionally mandated Competitive
Acquisition for Part B Drugs and
Biologicals Program (CAP). Medicare
Prescription Drug Improvement and
Modernization Act (MMA) section
303(d) requires the implementation of
the CAP for those drugs and biologicals
covered by Medicare part B that are not
paid on a cost or prospective payment
system. Since July 1, 2006, physicians
have been given a choice between (1)
Buying and billing for these covered
drugs under the average sales price
(ASP) system mandated in section
E:\FR\FM\20APN1.SGM
20APN1
19935
Federal Register / Vol. 72, No. 76 / Friday, April 20, 2007 / Notices
303(c) of the MMA; or (2) obtaining
these drugs from vendors selected for
the CAP in a competitive bidding
process. If the physician elects to obtain
drugs from a CAP vendor, the vendor,
rather than the physician, will bill
Medicare for the drug. The CAP is
therefore a major change in the way Part
B-covered drugs and biologicals are
acquired and reimbursed for, requiring
CMS to consider many design options.
The CAP mandate includes a Report to
Congress due July, 1 2008, which will
include results from this physician
survey; Frequency: Reporting—Once;
Affected Public: Business or Other forprofits; Number of Respondents: 1560;
Total Annual Responses: 1560; Total
Annual Hours: 297.50.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web Site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received at the address below, no
later than 5 p.m. on June 19, 2007.
CMS, Office of Strategic Operations
and Regulatory Affairs, Division of
Regulations Development—C, Attention:
Bonnie L Harkless, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
Dated: April 13, 2007.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. E7–7423 Filed 4–19–07; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Grant Application Data
Summary (GADS) Form.
OMB No.: New Collection.
Description: The Grant Application
Data Summary (GADS) collects
information from applicants seeking
grants from the Administration for
Native Americans (ANA). ANA awards
annual grants in three competitive areas.
Previously, ANA collected information
using a separate form for each
competitive area (OMB No. 0970–0261,
OMB No. 0970–0263, and OMB No.
0970–0265). ANA has consolidated the
three previous information collections
into the single GADS instrument.
Respondents: Tribal Governments,
Native Non-profits, Tribal Colleges and
Universities.
ANNUAL BURDEN ESTIMATES
Instrument
Number of respondents
Number of responses per
respondent
Average burden hours per
response
Total burden
hours
Grant Application Summary .............................................................................
500
1
.5
250
Estimated Total Annual Burden
Hours: 250.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Administration, Office of Information
Services, 370 L’Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF
Reports Clearance Officer. All requests
should be identified by the title of the
information collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Fax: 202–395–6974,
Attn: Desk Officer for the
Administration for Children and
Families.
Dated: April 16, 2007.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 07–1965 Filed 4–19–07; 8:45 am]
BILLING CODE 4184–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Protection and Advocacy (P&A)
Voting Access Annual Report.
OMB No.: New Collection.
Description: An annual report is
required by Federal statute (the Help
America Vote Act (HAVA) of 2002,
Public Law 107–252, Section 291,
Payments for Protection and Advocacy
Systems, 42 U.S.C. 15461). Each State
Protection & Advocacy (P&A) System
must prepare and submit an annual
report at the end of every fiscal year.
The report addresses the activities
conducted with the funds provided
during the year. The information from
the annual report will be aggregated into
an annual profile of how HAVA funds
have been spent. The report will also
provide an overview of the P&A goals
and accomplishments and permit the
Administration on Developmental
Disabilities to track progress to monitor
grant activities.
Respondents: Protection & Advocacy
Systems—All States, the District of
Columbia, Puerto Rico, the U.S. Virgin
Islands, American Samoa, and Guam.
sroberts on PROD1PC70 with NOTICES
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of responses per
respondent
Average
burden hours
per response
Total burden
hours
Protection and Advocacy (P&A) Voting Access Annual Report ......................
55
1
16
880
VerDate Aug<31>2005
18:52 Apr 19, 2007
Jkt 211001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
E:\FR\FM\20APN1.SGM
20APN1
Agencies
[Federal Register Volume 72, Number 76 (Friday, April 20, 2007)]
[Notices]
[Pages 19934-19935]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-7423]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-10217, CMS-R-297 and CMS-10223]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid
Services (CMS) is publishing the following summary of proposed
collections for public comment. Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
1. Type of Information Collection Request: New collection; Title of
Information Collection: Physician Survey for the 2006 Medicare Oncology
Demonstration Program; Form Numbers: CMS-10217 (OMB: 0938-
New); Use: The 2006 Oncology Demonstration Program aimed to: (1) Have
oncology payments increasingly focused on patient-centered care, rather
than chemotherapy administration; (2) learn to what extent Medicare
beneficiaries are being treated in a manner that yields the best
outcomes; (3) understand clinical cancer scenarios where there is not
clinical consensus among physicians on the relevance of specific
evidence-based practice guidelines; and, (4) ensure that due emphasis
is placed on multi-disciplinary, comprehensive approach to palliation
and end of life care. In addition, CMS hoped to reduce the potential
that unnecessary services and tests are being performed, thereby
lowering program costs while yielding better quality of life for
Medicare beneficiaries with cancer. This survey will provide
information on how physicians, particularly oncologists and
hematologists, adapted their practice in response to the CMS payment
incentive, to guide future CMS demonstration projects involving
oncologists and all specialists. Frequency: Reporting--Once; Affected
Public: Individuals or households; Number of Respondents: 600; Total
Annual Responses: 600; Total Annual Hours: 100.
2. Type of Information Collection Request: Extension without change
of a currently approved collection; Title of Information Collection:
Request for Employment Information; Form Numbers: CMS-R-297
(OMB: 0938-0787); Use: Section 1837(i) of the Social Security
Act provides for a special enrollment period for individuals who delay
enrolling in Medicare Part B because they are covered by a group health
plan based on their own or a spouse's current employment status. When
these individuals apply for Medicare Part B, they must provide proof
that the group health plan coverage is (or was) based on current
employment status. This form is used by the Social Security
Administration to obtain information from employers regarding whether a
Medicare beneficiary's coverage under a group health plan is based on
current employment status. Frequency: Reporting--Once; Affected Public:
Business or Other for profit and Not-for-profit institutions; Number of
Respondents: 5000; Total Annual Responses: 5000; Total Annual Hours:
1250.
3. Type of Information Collection Request: New collection; Title of
Information Collection: Medicare Competitive Acquisition Program (CAP)
for Part B Drugs Evaluation: CAP Physician Survey; Form Numbers: CMS-
10223 (OMB: 0938-New); Use: This physician survey is part of
an overall evaluation of the Centers for Medicare and Medicaid Services
congressionally mandated Competitive Acquisition for Part B Drugs and
Biologicals Program (CAP). Medicare Prescription Drug Improvement and
Modernization Act (MMA) section 303(d) requires the implementation of
the CAP for those drugs and biologicals covered by Medicare part B that
are not paid on a cost or prospective payment system. Since July 1,
2006, physicians have been given a choice between (1) Buying and
billing for these covered drugs under the average sales price (ASP)
system mandated in section
[[Page 19935]]
303(c) of the MMA; or (2) obtaining these drugs from vendors selected
for the CAP in a competitive bidding process. If the physician elects
to obtain drugs from a CAP vendor, the vendor, rather than the
physician, will bill Medicare for the drug. The CAP is therefore a
major change in the way Part B-covered drugs and biologicals are
acquired and reimbursed for, requiring CMS to consider many design
options. The CAP mandate includes a Report to Congress due July, 1
2008, which will include results from this physician survey; Frequency:
Reporting--Once; Affected Public: Business or Other for-profits; Number
of Respondents: 1560; Total Annual Responses: 1560; Total Annual Hours:
297.50.
To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, access CMS'
Web Site address at https://www.cms.hhs.gov/PaperworkReductionActof1995,
or E-mail your request, including your address, phone number, OMB
number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call
the Reports Clearance Office on (410) 786-1326.
To be assured consideration, comments and recommendations for the
proposed information collections must be received at the address below,
no later than 5 p.m. on June 19, 2007.
CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development--C, Attention: Bonnie L Harkless,
Room C4-26-05, 7500 Security Boulevard, Baltimore, Maryland 21244-1850.
Dated: April 13, 2007.
Michelle Shortt,
Director, Regulations Development Group, Office of Strategic Operations
and Regulatory Affairs.
[FR Doc. E7-7423 Filed 4-19-07; 8:45 am]
BILLING CODE 4120-01-P